Stanford University, Stanford, CA, USA.
Int J Stroke. 2014 Feb;9(2):156-9. doi: 10.1111/ijs.12230. Epub 2013 Dec 23.
Reperfusion is associated with good functional outcome after stroke. However, minimal data are available regarding the effect of reperfusion on clinical outcome and infarct growth in patients with distal MCA branch occlusions.
The aim of this study was to evaluate this association and to determine the impact of the perfusion-diffusion mismatch.
Individual patient data from three stroke studies (EPITHET, DEFUSE and DEFUSE 2) with baseline MRI profiles and reperfusion status were pooled. Patients were included if they had a single cortical perfusion lesion on their baseline MRI that was consistent with a distal MCA branch occlusion. Good functional outcome was defined as a score of 0-2 on the modified Rankin Scale at day 90 and infarct growth was defined as change in lesion volume between the baseline DWI and the final T2/FLAIR.
Thirty patients met inclusion criteria. Eighteen (60%) had a good functional outcome and twenty (67%) had reperfusion. Reperfusion was not associated with good functional outcome in the overall cohort (OR: 1·0, 95% CI 0·2-4·7) and also not in the subset of patients with a PWI-DWI mismatch (n = 17; OR: 0·7, 95% CI 0·1-5·5). Median infarct growth was modest and not significantly different between patients with (0 ml) and without reperfusion (6 ml); P = 0·2.
The overall high rate of good outcomes in patients with distal MCA perfusion lesions might obscure a potential benefit from reperfusion in this population. A larger pooled analysis evaluating the effect of reperfusion in patients with distal MCA branch occlusions is warranted as confirmation of our results could have implications for the design of future stroke trials.
再灌注与卒中后良好的功能结局相关。然而,关于再灌注对大脑中动脉远端分支闭塞患者的临床结局和梗死灶增长的影响,仅有少量数据。
本研究旨在评估这种相关性,并确定灌注-弥散不匹配的影响。
将三个卒中研究(EPITHET、DEFUSE 和 DEFUSE 2)的个体患者数据进行汇总,这些研究具有基线 MRI 特征和再灌注状态。如果患者的基线 MRI 上存在单一皮质灌注病变,且与大脑中动脉远端分支闭塞一致,则将其纳入研究。良好的功能结局定义为 90 天时改良 Rankin 量表评分为 0-2 分,梗死灶增长定义为基线 DWI 与最终 T2/FLAIR 之间的病变体积变化。
30 名患者符合纳入标准。18 名(60%)患者功能结局良好,20 名(67%)患者发生再灌注。再灌注与整体队列的良好功能结局无关(OR:1.0,95%CI 0.2-4.7),在存在灌注-弥散不匹配的患者亚组中(n=17;OR:0.7,95%CI 0.1-5.5)也无关。梗死灶增长中位数较低,且再灌注组与无再灌注组之间无显著差异(6ml);P=0.2。
大脑中动脉远端灌注病变患者的整体高良好结局率可能掩盖了该人群再灌注的潜在益处。需要进一步进行更大规模的汇总分析,以评估再灌注对大脑中动脉远端分支闭塞患者的影响,因为我们研究结果的证实可能对未来卒中试验的设计产生影响。